Inside informationEnglish
Nicox Announces up to €3 million in Milestone Payments from Kowa in 2025 as NCX 470 Prepares to Enter Phase 3 Clinical Trials in Japan
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Nicox SA
- Filed
- 27/05/2025, 07:30
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 119023_20250527